Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (181-190 of 526) with videos related to

Pageof 53
Sort By:
Cancer Treatment Reviews|September 22, 2019
Molecular targeted therapy of glioblastomaEmilie Le Rhun, Matthias Preusser, Patrick Roth, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2024
Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patientsGeorg Jeryczynski, Christoph Krall, Sabina Pasalic, et al.
The American Journal of Surgical Pathology|May 18, 2012
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinomaOskar Koperek, Christoph Kornauth, David Capper, et al.
Annals of Hematology|July 25, 2014
A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?Konstantin Schlick, Marlene Troch, Gudrun Placher-Sorko, et al.
Neuro-Oncology|August 20, 2017
Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatmentMartina Schneider, Eva-Maria Reitter, Marie-Theres Kastner, et al.
ESMO Open|September 1, 2018
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussionMatthias Preusser, Leticia De Mattos-Arruda, Marc Thill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE TrialsJulia Furtner, Michael Weller, Michael Weber, et al.
Wiener Klinische Wochenschrift|May 31, 2023
Screening for colorectal cancer : A recommendation statement of the Austrian National Committee for Cancer ScreeningGerald Gartlehner, Eva Schernhammer, Sigurd F Lax, et al.
Journal of Neuro-Oncology|March 2, 2021
LAG-3 expression in the inflammatory microenvironment of gliomaMaximilian J Mair, Barbara Kiesel, Katharina Feldmann, et al.
Clinical Neuropathology|December 5, 2015
Lack of P-glycoprotein expression in melanoma brain metastases of different melanoma typesErika Richtig, Martin Asslaber, Richard Partl, et al.
Pageof 53

Showing results (181-190 of 526) with videos related to

Sort By:
Pageof 53
Cancer Treatment Reviews|September 22, 2019
Molecular targeted therapy of glioblastomaEmilie Le Rhun, Matthias Preusser, Patrick Roth, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2024
Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patientsGeorg Jeryczynski, Christoph Krall, Sabina Pasalic, et al.
The American Journal of Surgical Pathology|May 18, 2012
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinomaOskar Koperek, Christoph Kornauth, David Capper, et al.
Annals of Hematology|July 25, 2014
A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?Konstantin Schlick, Marlene Troch, Gudrun Placher-Sorko, et al.
Neuro-Oncology|August 20, 2017
Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatmentMartina Schneider, Eva-Maria Reitter, Marie-Theres Kastner, et al.
ESMO Open|September 1, 2018
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussionMatthias Preusser, Leticia De Mattos-Arruda, Marc Thill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE TrialsJulia Furtner, Michael Weller, Michael Weber, et al.
Wiener Klinische Wochenschrift|May 31, 2023
Screening for colorectal cancer : A recommendation statement of the Austrian National Committee for Cancer ScreeningGerald Gartlehner, Eva Schernhammer, Sigurd F Lax, et al.
Journal of Neuro-Oncology|March 2, 2021
LAG-3 expression in the inflammatory microenvironment of gliomaMaximilian J Mair, Barbara Kiesel, Katharina Feldmann, et al.
Clinical Neuropathology|December 5, 2015
Lack of P-glycoprotein expression in melanoma brain metastases of different melanoma typesErika Richtig, Martin Asslaber, Richard Partl, et al.
Pageof 53